KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CRISPR Therapeutics AG (CRSP) Tax Provisions (2016 - 2025)

CRISPR Therapeutics AG (CRSP) has disclosed Tax Provisions for 11 consecutive years, with $634000.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions fell 46.45% to $634000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, down 10.99% year-over-year, with the annual reading at $3.6 million for FY2025, 10.73% down from the prior year.
  • Tax Provisions hit $634000.0 in Q4 2025 for CRISPR Therapeutics AG, up from $600000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $6.1 million in Q2 2022 to a low of -$8.5 million in Q4 2022.
  • Historically, Tax Provisions has averaged $566550.0 across 5 years, with a median of $800000.0 in 2023.
  • Biggest YoY gain for Tax Provisions was 981.79% in 2021; the steepest drop was 563.0% in 2021.
  • Year by year, Tax Provisions stood at -$4.0 million in 2021, then tumbled by 112.82% to -$8.5 million in 2022, then skyrocketed by 102.22% to $188000.0 in 2023, then skyrocketed by 529.79% to $1.2 million in 2024, then crashed by 46.45% to $634000.0 in 2025.
  • Business Quant data shows Tax Provisions for CRSP at $634000.0 in Q4 2025, $600000.0 in Q3 2025, and $1.3 million in Q2 2025.